APO Research

APO RESEARCH · REPORT

Exoskeleton Enhancement Device

Selected research

Market Analysis & Forecast

Global Exoskeleton Enhancement Device Market Analysis and Forecast 2026-2032

Market perspective

The global Exoskeleton Enhancement Device market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Exoskeleton Enhancement Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Exoskeleton Enhancement Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Exoskeleton Enhancement Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Exoskeleton Enhancement Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Exoskeleton Enhancement Device include Parker Hannifin, US Bionics, ReWalk Robotics, Panasonic, Myomo, LockHeed Martin, Interactive Motion Technologies, Hocoma and Ekso Bionics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Exoskeleton Enhancement Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Exoskeleton Enhancement Device, also provides the sales of main regions and countries. Of the upcoming market potential for Exoskeleton Enhancement Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Exoskeleton Enhancement Device sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Exoskeleton Enhancement Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Exoskeleton Enhancement Device sales, projected growth trends, production technology, application and end-user industry.

Exoskeleton Enhancement Device Segment by Company

Parker Hannifin

US Bionics

ReWalk Robotics

Panasonic

Myomo

LockHeed Martin

Interactive Motion Technologies

Hocoma

Ekso Bionics

Cyberdyne

B-TEMIA Inc.

Alter G

Exoskeleton Enhancement Device Segment by Type

Lower

Upper

Full Body

Exoskeleton Enhancement Device Segment by Application

Healthcare

Defense

Others

Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Exoskeleton Enhancement Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exoskeleton Enhancement Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Exoskeleton Enhancement Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lower Major Manufacturers Table 3. Upper Major Manufacturers Table 4. Full Body Major Manufacturers Table 5. Global Exoskeleton Enhancement Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Healthcare Major Manufacturers Table 7. Defense Major Manufacturers Table 8. Others Major Manufacturers Table 9. Exoskeleton Enhancement Device Industry Trends Table 10. Exoskeleton Enhancement Device Industry Drivers Table 11. Exoskeleton Enhancement Device Industry Opportunities and Challenges Table 12. Exoskeleton Enhancement Device Industry Restraints Table 13. Global Exoskeleton Enhancement Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Exoskeleton Enhancement Device Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Exoskeleton Enhancement Device Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2026) Table 17. Global Exoskeleton Enhancement Device Revenue Market Share by Region (2027-2032) Table 18. Global Exoskeleton Enhancement Device Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 19. Global Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 20. Global Exoskeleton Enhancement Device Sales by Region (2027-2032) & (Units) Table 21. Global Exoskeleton Enhancement Device Sales Market Share by Region (2021-2026) Table 22. Global Exoskeleton Enhancement Device Sales Market Share by Region (2027-2032) Table 23. Global Exoskeleton Enhancement Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Exoskeleton Enhancement Device Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Exoskeleton Enhancement Device Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021-2026) Table 27. Global Exoskeleton Enhancement Device Sales Price (K US$/Unit) of Manufacturers (2021-2026) Table 28. Global Exoskeleton Enhancement Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Exoskeleton Enhancement Device Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Exoskeleton Enhancement Device Manufacturers, Product Type & Application Table 31. Global Exoskeleton Enhancement Device Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Exoskeleton Enhancement Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Exoskeleton Enhancement Device Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2026) Table 38. Global Exoskeleton Enhancement Device Revenue Market Share by Type (2027-2032) Table 39. Global Exoskeleton Enhancement Device Sales by Type 2021 VS 2025 VS 2032 (Units) Table 40. Global Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 41. Global Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 42. Global Exoskeleton Enhancement Device Sales Market Share by Type (2021-2026) Table 43. Global Exoskeleton Enhancement Device Sales Market Share by Type (2027-2032) Table 44. Global Exoskeleton Enhancement Device Price by Type (2021-2026) & (K US$/Unit) Table 45. Global Exoskeleton Enhancement Device Price by Type (2027-2032) & (K US$/Unit) Table 46. Global Exoskeleton Enhancement Device Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2026) Table 50. Global Exoskeleton Enhancement Device Revenue Market Share by Application (2027-2032) Table 51. Global Exoskeleton Enhancement Device Sales by Application 2021 VS 2025 VS 2032 (Units) Table 52. Global Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 53. Global Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 54. Global Exoskeleton Enhancement Device Sales Market Share by Application (2021-2026) Table 55. Global Exoskeleton Enhancement Device Sales Market Share by Application (2027-2032) Table 56. Global Exoskeleton Enhancement Device Price by Application (2021-2026) & (K US$/Unit) Table 57. Global Exoskeleton Enhancement Device Price by Application (2027-2032) & (K US$/Unit) Table 58. Parker Hannifin Company Information Table 59. Parker Hannifin Business Overview Table 60. Parker Hannifin Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 61. Parker Hannifin Exoskeleton Enhancement Device Product Portfolio Table 62. Parker Hannifin Recent Development Table 63. US Bionics Company Information Table 64. US Bionics Business Overview Table 65. US Bionics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 66. US Bionics Exoskeleton Enhancement Device Product Portfolio Table 67. US Bionics Recent Development Table 68. ReWalk Robotics Company Information Table 69. ReWalk Robotics Business Overview Table 70. ReWalk Robotics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 71. ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio Table 72. ReWalk Robotics Recent Development Table 73. Panasonic Company Information Table 74. Panasonic Business Overview Table 75. Panasonic Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 76. Panasonic Exoskeleton Enhancement Device Product Portfolio Table 77. Panasonic Recent Development Table 78. Myomo Company Information Table 79. Myomo Business Overview Table 80. Myomo Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 81. Myomo Exoskeleton Enhancement Device Product Portfolio Table 82. Myomo Recent Development Table 83. LockHeed Martin Company Information Table 84. LockHeed Martin Business Overview Table 85. LockHeed Martin Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 86. LockHeed Martin Exoskeleton Enhancement Device Product Portfolio Table 87. LockHeed Martin Recent Development Table 88. Interactive Motion Technologies Company Information Table 89. Interactive Motion Technologies Business Overview Table 90. Interactive Motion Technologies Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 91. Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio Table 92. Interactive Motion Technologies Recent Development Table 93. Hocoma Company Information Table 94. Hocoma Business Overview Table 95. Hocoma Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 96. Hocoma Exoskeleton Enhancement Device Product Portfolio Table 97. Hocoma Recent Development Table 98. Ekso Bionics Company Information Table 99. Ekso Bionics Business Overview Table 100. Ekso Bionics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 101. Ekso Bionics Exoskeleton Enhancement Device Product Portfolio Table 102. Ekso Bionics Recent Development Table 103. Cyberdyne Company Information Table 104. Cyberdyne Business Overview Table 105. Cyberdyne Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 106. Cyberdyne Exoskeleton Enhancement Device Product Portfolio Table 107. Cyberdyne Recent Development Table 108. B-TEMIA Inc. Company Information Table 109. B-TEMIA Inc. Business Overview Table 110. B-TEMIA Inc. Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 111. B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio Table 112. B-TEMIA Inc. Recent Development Table 113. Alter G Company Information Table 114. Alter G Business Overview Table 115. Alter G Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 116. Alter G Exoskeleton Enhancement Device Product Portfolio Table 117. Alter G Recent Development Table 118. North America Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 121. North America Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 122. North America Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (K US$/Unit) Table 123. North America Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (K US$/Unit) Table 124. North America Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 127. North America Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 128. North America Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (K US$/Unit) Table 129. North America Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (K US$/Unit) Table 130. North America Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Exoskeleton Enhancement Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 134. North America Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 135. North America Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 136. North America Exoskeleton Enhancement Device Sales Price by Country (2021-2026) & (K US$/Unit) Table 137. North America Exoskeleton Enhancement Device Sales Price by Country (2027-2032) & (K US$/Unit) Table 138. United States Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 139. Canada Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 140. Mexico Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 141. Europe Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 144. Europe Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 145. Europe Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (K US$/Unit) Table 146. Europe Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (K US$/Unit) Table 147. Europe Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 150. Europe Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 151. Europe Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (K US$/Unit) Table 152. Europe Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (K US$/Unit) Table 153. Europe Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Exoskeleton Enhancement Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 157. Europe Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 158. Europe Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 159. Europe Exoskeleton Enhancement Device Sales Price by Country (2021-2026) & (K US$/Unit) Table 160. Europe Exoskeleton Enhancement Device Sales Price by Country (2027-2032) & (K US$/Unit) Table 161. Germany Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 162. France Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 163. U.K. Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 164. Italy Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 165. Russia Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 166. Spain Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 168. Switzerland Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 169. Sweden Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 170. Poland Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 171. China Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 172. China Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 173. China Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 174. China Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 175. China Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (K US$/Unit) Table 176. China Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (K US$/Unit) Table 177. China Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 178. China Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 179. China Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 180. China Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 181. China Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (K US$/Unit) Table 182. China Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (K US$/Unit) Table 183. Asia Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 186. Asia Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 187. Asia Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (K US$/Unit) Table 188. Asia Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (K US$/Unit) Table 189. Asia Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 192. Asia Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 193. Asia Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (K US$/Unit) Table 194. Asia Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (K US$/Unit) Table 195. Asia Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Exoskeleton Enhancement Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 199. Asia Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 200. Asia Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 201. Asia Exoskeleton Enhancement Device Sales Price by Country (2021-2026) & (K US$/Unit) Table 202. Asia Exoskeleton Enhancement Device Sales Price by Country (2027-2032) & (K US$/Unit) Table 203. Japan Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 204. South Korea Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 205. India Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 206. Australia Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 207. Taiwan Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 212. SAMEA Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 213. SAMEA Exoskeleton Enhancement Device Sales Price by Type (2021-2026) & (K US$/Unit) Table 214. SAMEA Exoskeleton Enhancement Device Sales Price by Type (2027-2032) & (K US$/Unit) Table 215. SAMEA Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 218. SAMEA Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 219. SAMEA Exoskeleton Enhancement Device Sales Price by Application (2021-2026) & (K US$/Unit) Table 220. SAMEA Exoskeleton Enhancement Device Sales Price by Application (2027-2032) & (K US$/Unit) Table 221. SAMEA Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Exoskeleton Enhancement Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 225. SAMEA Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 226. SAMEA Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 227. SAMEA Exoskeleton Enhancement Device Sales Price by Country (2021-2026) & (K US$/Unit) Table 228. SAMEA Exoskeleton Enhancement Device Sales Price by Country (2027-2032) & (K US$/Unit) Table 229. Brazil Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 230. Argentina Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 231. Chile Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 232. Colombia Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 233. Peru Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 235. Israel Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 236. UAE Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 237. Turkey Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 238. Iran Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 239. Egypt Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Exoskeleton Enhancement Device Distributors List Table 243. Exoskeleton Enhancement Device Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Exoskeleton Enhancement Device Image Figure 2. Global Exoskeleton Enhancement Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exoskeleton Enhancement Device Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lower Image Figure 5. Upper Image Figure 6. Full Body Image Figure 7. Global Exoskeleton Enhancement Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Exoskeleton Enhancement Device Market Size Share 2021 VS 2025 VS 2032 Figure 9. Healthcare Image Figure 10. Defense Image Figure 11. Others Image Figure 12. Global Exoskeleton Enhancement Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 14. Global Exoskeleton Enhancement Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Exoskeleton Enhancement Device Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2032) Figure 17. Global Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 18. Global Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 19. Global Exoskeleton Enhancement Device Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 21. Europe Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 22. China Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 23. Asia (Excluding China) Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 24. South America, Middle East and Africa Exoskeleton Enhancement Device Sales YoY (2021-2032) & (Units) Figure 25. Global Exoskeleton Enhancement Device Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Exoskeleton Enhancement Device Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Exoskeleton Enhancement Device Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Exoskeleton Enhancement Device Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032) Figure 31. Global Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 32. Global Exoskeleton Enhancement Device Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032) Figure 34. Global Exoskeleton Enhancement Device Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Exoskeleton Enhancement Device Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032) Figure 37. Global Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 38. Global Exoskeleton Enhancement Device Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032) Figure 40. North America Exoskeleton Enhancement Device Revenue Share by Type (2021-2032) Figure 41. North America Exoskeleton Enhancement Device Sales Share by Type (2021-2032) Figure 42. North America Exoskeleton Enhancement Device Revenue Share by Application (2021-2032) Figure 43. North America Exoskeleton Enhancement Device Sales Share by Application (2021-2032) Figure 44. North America Exoskeleton Enhancement Device Revenue Share by Country (2021-2032) Figure 45. North America Exoskeleton Enhancement Device Sales Share by Country (2021-2032) Figure 46. Europe Exoskeleton Enhancement Device Revenue Share by Type (2021-2032) Figure 47. Europe Exoskeleton Enhancement Device Sales Share by Type (2021-2032) Figure 48. Europe Exoskeleton Enhancement Device Revenue Share by Application (2021-2032) Figure 49. Europe Exoskeleton Enhancement Device Sales Share by Application (2021-2032) Figure 50. Europe Exoskeleton Enhancement Device Revenue Share by Country (2021-2032) Figure 51. Europe Exoskeleton Enhancement Device Sales Share by Country (2021-2032) Figure 52. China Exoskeleton Enhancement Device Revenue Share by Type (2021-2032) Figure 53. China Exoskeleton Enhancement Device Sales Share by Type (2021-2032) Figure 54. China Exoskeleton Enhancement Device Revenue Share by Application (2021-2032) Figure 55. China Exoskeleton Enhancement Device Sales Share by Application (2021-2032) Figure 56. Asia Exoskeleton Enhancement Device Revenue Share by Type (2021-2032) Figure 57. Asia Exoskeleton Enhancement Device Sales Share by Type (2021-2032) Figure 58. Asia Exoskeleton Enhancement Device Revenue Share by Application (2021-2032) Figure 59. Asia Exoskeleton Enhancement Device Sales Share by Application (2021-2032) Figure 60. Asia Exoskeleton Enhancement Device Revenue Share by Country (2021-2032) Figure 61. Asia Exoskeleton Enhancement Device Sales Share by Country (2021-2032) Figure 62. SAMEA Exoskeleton Enhancement Device Revenue Share by Type (2021-2032) Figure 63. SAMEA Exoskeleton Enhancement Device Sales Share by Type (2021-2032) Figure 64. SAMEA Exoskeleton Enhancement Device Revenue Share by Application (2021-2032) Figure 65. SAMEA Exoskeleton Enhancement Device Sales Share by Application (2021-2032) Figure 66. SAMEA Exoskeleton Enhancement Device Revenue Share by Country (2021-2032) Figure 67. SAMEA Exoskeleton Enhancement Device Sales Share by Country (2021-2032) Figure 68. Exoskeleton Enhancement Device Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Exoskeleton Enhancement Device Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Lower
  • Upper
  • Full Body
Applications
  • Healthcare
  • Defense
  • Others
Companies covered
  • Parker Hannifin
  • US Bionics
  • ReWalk Robotics
  • Panasonic
  • Myomo
  • LockHeed Martin
  • Interactive Motion Technologies
  • Hocoma
  • Ekso Bionics
  • Cyberdyne
  • B-TEMIA Inc.
  • Alter G

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Exoskeleton Enhancement Device Market by Type
  3. 1.2.1 Global Exoskeleton Enhancement Device Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lower
  5. 1.2.3 Upper
  6. 1.2.4 Full Body
  7. 1.3 Exoskeleton Enhancement Device Market by Application
  8. 1.3.1 Global Exoskeleton Enhancement Device Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Healthcare
  10. 1.3.3 Defense
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Exoskeleton Enhancement Device Market Dynamics
  1. 2.1 Exoskeleton Enhancement Device Industry Trends
  2. 2.2 Exoskeleton Enhancement Device Industry Drivers
  3. 2.3 Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 2.4 Exoskeleton Enhancement Device Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Exoskeleton Enhancement Device Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Exoskeleton Enhancement Device Revenue by Region
  3. 3.2.1 Global Exoskeleton Enhancement Device Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Exoskeleton Enhancement Device Revenue by Region (2021-2026)
  5. 3.2.3 Global Exoskeleton Enhancement Device Revenue by Region (2027-2032)
  6. 3.2.4 Global Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Exoskeleton Enhancement Device Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Exoskeleton Enhancement Device Sales by Region
  9. 3.4.1 Global Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Exoskeleton Enhancement Device Sales by Region (2021-2026)
  11. 3.4.3 Global Exoskeleton Enhancement Device Sales by Region (2027-2032)
  12. 3.4.4 Global Exoskeleton Enhancement Device Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Exoskeleton Enhancement Device Revenue by Manufacturers
  2. 4.1.1 Global Exoskeleton Enhancement Device Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Exoskeleton Enhancement Device Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Exoskeleton Enhancement Device Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Exoskeleton Enhancement Device Sales by Manufacturers
  6. 4.2.1 Global Exoskeleton Enhancement Device Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Exoskeleton Enhancement Device Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Exoskeleton Enhancement Device Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Exoskeleton Enhancement Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Exoskeleton Enhancement Device Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Exoskeleton Enhancement Device Manufacturers, Product Type & Application
  13. 4.7 Global Exoskeleton Enhancement Device Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Exoskeleton Enhancement Device Market CR5 and HHI
  16. 4.8.2 2025 Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3
5 Exoskeleton Enhancement Device Market by Type
  1. 5.1 Global Exoskeleton Enhancement Device Revenue by Type
  2. 5.1.1 Global Exoskeleton Enhancement Device Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Exoskeleton Enhancement Device Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Exoskeleton Enhancement Device Sales by Type
  6. 5.2.1 Global Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Exoskeleton Enhancement Device Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032)
  9. 5.3 Global Exoskeleton Enhancement Device Price by Type
6 Exoskeleton Enhancement Device Market by Application
  1. 6.1 Global Exoskeleton Enhancement Device Revenue by Application
  2. 6.1.1 Global Exoskeleton Enhancement Device Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Exoskeleton Enhancement Device Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Exoskeleton Enhancement Device Sales by Application
  6. 6.2.1 Global Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Exoskeleton Enhancement Device Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032)
  9. 6.3 Global Exoskeleton Enhancement Device Price by Application
7 Company Profiles
  1. 7.1 Parker Hannifin
  2. 7.1.1 Parker Hannifin Company Information
  3. 7.1.2 Parker Hannifin Business Overview
  4. 7.1.3 Parker Hannifin Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Parker Hannifin Exoskeleton Enhancement Device Product Portfolio
  6. 7.1.5 Parker Hannifin Recent Developments
  7. 7.2 US Bionics
  8. 7.2.1 US Bionics Company Information
  9. 7.2.2 US Bionics Business Overview
  10. 7.2.3 US Bionics Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 US Bionics Exoskeleton Enhancement Device Product Portfolio
  12. 7.2.5 US Bionics Recent Developments
  13. 7.3 ReWalk Robotics
  14. 7.3.1 ReWalk Robotics Company Information
  15. 7.3.2 ReWalk Robotics Business Overview
  16. 7.3.3 ReWalk Robotics Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio
  18. 7.3.5 ReWalk Robotics Recent Developments
  19. 7.4 Panasonic
  20. 7.4.1 Panasonic Company Information
  21. 7.4.2 Panasonic Business Overview
  22. 7.4.3 Panasonic Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Panasonic Exoskeleton Enhancement Device Product Portfolio
  24. 7.4.5 Panasonic Recent Developments
  25. 7.5 Myomo
  26. 7.5.1 Myomo Company Information
  27. 7.5.2 Myomo Business Overview
  28. 7.5.3 Myomo Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Myomo Exoskeleton Enhancement Device Product Portfolio
  30. 7.5.5 Myomo Recent Developments
  31. 7.6 LockHeed Martin
  32. 7.6.1 LockHeed Martin Company Information
  33. 7.6.2 LockHeed Martin Business Overview
  34. 7.6.3 LockHeed Martin Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 LockHeed Martin Exoskeleton Enhancement Device Product Portfolio
  36. 7.6.5 LockHeed Martin Recent Developments
  37. 7.7 Interactive Motion Technologies
  38. 7.7.1 Interactive Motion Technologies Company Information
  39. 7.7.2 Interactive Motion Technologies Business Overview
  40. 7.7.3 Interactive Motion Technologies Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio
  42. 7.7.5 Interactive Motion Technologies Recent Developments
  43. 7.8 Hocoma
  44. 7.8.1 Hocoma Company Information
  45. 7.8.2 Hocoma Business Overview
  46. 7.8.3 Hocoma Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hocoma Exoskeleton Enhancement Device Product Portfolio
  48. 7.8.5 Hocoma Recent Developments
  49. 7.9 Ekso Bionics
  50. 7.9.1 Ekso Bionics Company Information
  51. 7.9.2 Ekso Bionics Business Overview
  52. 7.9.3 Ekso Bionics Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ekso Bionics Exoskeleton Enhancement Device Product Portfolio
  54. 7.9.5 Ekso Bionics Recent Developments
  55. 7.10 Cyberdyne
  56. 7.10.1 Cyberdyne Company Information
  57. 7.10.2 Cyberdyne Business Overview
  58. 7.10.3 Cyberdyne Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cyberdyne Exoskeleton Enhancement Device Product Portfolio
  60. 7.10.5 Cyberdyne Recent Developments
  61. 7.11 B-TEMIA Inc.
  62. 7.11.1 B-TEMIA Inc. Company Information
  63. 7.11.2 B-TEMIA Inc. Business Overview
  64. 7.11.3 B-TEMIA Inc. Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio
  66. 7.11.5 B-TEMIA Inc. Recent Developments
  67. 7.12 Alter G
  68. 7.12.1 Alter G Company Information
  69. 7.12.2 Alter G Business Overview
  70. 7.12.3 Alter G Exoskeleton Enhancement Device Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Alter G Exoskeleton Enhancement Device Product Portfolio
  72. 7.12.5 Alter G Recent Developments
8 North America
  1. 8.1 North America Exoskeleton Enhancement Device Market Size by Type
  2. 8.1.1 North America Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 8.1.2 North America Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 8.1.3 North America Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 8.2 North America Exoskeleton Enhancement Device Market Size by Application
  6. 8.2.1 North America Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 8.2.2 North America Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 8.2.3 North America Exoskeleton Enhancement Device Price by Application (2021-2032)
  9. 8.3 North America Exoskeleton Enhancement Device Market Size by Country
  10. 8.3.1 North America Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Exoskeleton Enhancement Device Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Exoskeleton Enhancement Device Market Size by Type
  2. 9.1.1 Europe Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 9.1.2 Europe Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 9.1.3 Europe Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 9.2 Europe Exoskeleton Enhancement Device Market Size by Application
  6. 9.2.1 Europe Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 9.2.2 Europe Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 9.2.3 Europe Exoskeleton Enhancement Device Price by Application (2021-2032)
  9. 9.3 Europe Exoskeleton Enhancement Device Market Size by Country
  10. 9.3.1 Europe Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Exoskeleton Enhancement Device Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Exoskeleton Enhancement Device Market Size by Type
  2. 10.1.1 China Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 10.1.2 China Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 10.1.3 China Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 10.2 China Exoskeleton Enhancement Device Market Size by Application
  6. 10.2.1 China Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 10.2.2 China Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 10.2.3 China Exoskeleton Enhancement Device Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Exoskeleton Enhancement Device Market Size by Type
  2. 11.1.1 Asia Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 11.1.2 Asia Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 11.1.3 Asia Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 11.2 Asia Exoskeleton Enhancement Device Market Size by Application
  6. 11.2.1 Asia Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 11.2.2 Asia Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 11.2.3 Asia Exoskeleton Enhancement Device Price by Application (2021-2032)
  9. 11.3 Asia Exoskeleton Enhancement Device Market Size by Country
  10. 11.3.1 Asia Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Exoskeleton Enhancement Device Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Exoskeleton Enhancement Device Market Size by Type
  2. 12.1.1 SAMEA Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Exoskeleton Enhancement Device Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Exoskeleton Enhancement Device Price by Type (2021-2032)
  5. 12.2 SAMEA Exoskeleton Enhancement Device Market Size by Application
  6. 12.2.1 SAMEA Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Exoskeleton Enhancement Device Price by Application (2021-2032)
  9. 12.3 SAMEA Exoskeleton Enhancement Device Market Size by Country
  10. 12.3.1 SAMEA Exoskeleton Enhancement Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Exoskeleton Enhancement Device Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Exoskeleton Enhancement Device Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Exoskeleton Enhancement Device Value Chain Analysis
  2. 13.1.1 Exoskeleton Enhancement Device Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Exoskeleton Enhancement Device Production Mode & Process
  6. 13.2 Exoskeleton Enhancement Device Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Exoskeleton Enhancement Device Distributors
  9. 13.2.3 Exoskeleton Enhancement Device Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research